Research Spotlight: Comparing the GI Side Effects of Four Medications for Alcohol Use Disorder
Researchers found that injectable naltrexone had the fewest reported GI and liver-related side effects compared to the other drugs.
Request an appointment or second opinion with the Fertility Center or refer a patient.
Explore infertility research at the Massachusetts General Hospital Fertility Center and search open clinical trials and medical studies.
The Vincent Center for Reproductive Biology consists of basic and clinical scientists whose primary research emphasis includes infertility, aging and cancer as they pertain to the ovary and uterus. The center provides an optimal environment for individuals who are interested in integrating clinical and basic sciences and have a strong desire to pursue a career in academic research.
Search for clinical trials and research studies currently seeking participants.
The START Study tracks women’s mood symptoms throughout infertility treatment cycles. Study participants include women with a history of major depression or bipolar depression currently in remission who are planning or are under going infertility treatment. (Ongoing but not enrolling)
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
Our program trains OB/GYN subspecialists to manage complex infertility and reproductive endocrinology issues with an emphasis on research.
The Department of Obstetrics and Gynecology at Mass General has advanced the science and the quality of care for patients since 1891.
Researchers found that injectable naltrexone had the fewest reported GI and liver-related side effects compared to the other drugs.
Researchers used a unique 3D microfluidic model of tumors to investigate the mechanisms of treatment resistance to CAR-T cells.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital today announced topline results from Regimen F of the HEALEY ALS Platform Trial evaluating fosigotifator (ABBV-CLS-7262) in people living with amyotrophic lateral sclerosis (ALS).
Sean M. Healey & AMG Center Announces Topline Results in HEALEY ALS Platform Trial with eIF2B Agonist DNL343
Researchers found that genetic swaps in the gut microbiome are occurring much more frequently than previously thought and detected more than 100,000 swaps that hadn’t been seen before.
University of Minnesota, Essentia Health Dose First Participants in Sean M. Healey & AMG Center for ALS, Never Surrender Inc. Led Expanded Access Protocol Programs
OB/GYN Advances is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in obstetrics and gynecology.